IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BIGGIOGGERO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.035
NA - Nord America 2.954
EU - Europa 2.128
SA - Sud America 320
AF - Africa 83
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.814
SG - Singapore 895
CN - Cina 783
IT - Italia 560
GB - Regno Unito 384
VN - Vietnam 336
BD - Bangladesh 316
HK - Hong Kong 261
RU - Federazione Russa 243
BR - Brasile 237
DE - Germania 210
SE - Svezia 182
FR - Francia 121
CA - Canada 94
FI - Finlandia 90
NL - Olanda 89
IN - India 84
IE - Irlanda 73
JP - Giappone 60
TR - Turchia 60
ID - Indonesia 53
KR - Corea 46
CI - Costa d'Avorio 36
UA - Ucraina 32
AR - Argentina 31
IQ - Iraq 22
ES - Italia 21
CO - Colombia 20
BE - Belgio 19
MX - Messico 18
PL - Polonia 18
PH - Filippine 16
EU - Europa 14
TW - Taiwan 14
ZA - Sudafrica 14
AU - Australia 13
UZ - Uzbekistan 11
AT - Austria 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
IR - Iran 9
EC - Ecuador 8
MA - Marocco 8
MY - Malesia 8
PK - Pakistan 8
SA - Arabia Saudita 8
CL - Cile 7
GR - Grecia 7
LT - Lituania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
CH - Svizzera 5
DZ - Algeria 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
MD - Moldavia 4
NO - Norvegia 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AP - ???statistics.table.value.countryCode.AP??? 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EG - Egitto 3
KE - Kenya 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
AO - Angola 2
BB - Barbados 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
Totale 8.537
Salva come PNG Salva come JPEG
Città #
Singapore 473
Ashburn 371
Southend 302
Chandler 275
Hong Kong 241
San Jose 179
Dallas 172
Milan 161
Beijing 147
Santa Clara 117
Ho Chi Minh City 116
New York 112
Los Angeles 109
Council Bluffs 93
Princeton 83
Hanoi 80
Seattle 76
Dublin 72
Frankfurt am Main 62
Helsinki 54
Ann Arbor 53
Fairfield 51
Wilmington 51
Boardman 50
Rome 48
Lauterbourg 46
Moscow 46
Toronto 45
Dearborn 44
Guangzhou 39
Bengaluru 38
Buffalo 38
Abidjan 36
Bar Harbor 35
Jakarta 35
Tokyo 35
Grafing 34
Munich 30
Houston 28
Woodbridge 27
Hefei 25
Cambridge 23
Nanjing 22
Redmond 22
Haiphong 21
Montreal 21
Shanghai 21
Cangzhou 20
Des Moines 20
Bologna 19
Da Nang 19
Mountain View 18
Phoenix 18
São Paulo 17
The Dalles 17
Naples 15
Brussels 14
Istanbul 14
Jacksonville 14
San Diego 14
Sunnyvale 14
Bogotá 13
Columbus 13
Medford 13
London 12
Redwood City 12
Shenyang 12
Turku 12
Catania 11
Jinan 11
Seoul 11
Warsaw 11
Brooklyn 10
Chicago 10
Hebei 10
Sakarya 10
Somerville 10
Tashkent 10
Washington 10
Andover 9
Berlin 9
Izmir 9
Madrid 9
Nuremberg 9
Orem 9
Atlanta 8
Hangzhou 8
Porto Alegre 8
Serra 8
Stockholm 8
Changsha 7
Edinburgh 7
Fortaleza 7
Johannesburg 7
Palermo 7
San Francisco 7
Athens 6
Boston 6
Eitensheim 6
Fuzhou 6
Totale 4.853
Salva come PNG Salva come JPEG
Nome #
Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis : A multi-center retrospective analysis 487
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors 277
Baricitinib for COVID-19: a suitable treatment? 267
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic 263
Role of antimalarials in COVID-19 : observational data from a cohort of rheumatic patients 261
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 242
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs : an Italian multicentre study 237
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 226
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 217
The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events 211
Juvenile idiopathic arthritis in adulthood in a tertiary reference centre 184
Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort 183
The challenging definition of naïve patient for biological drug use 179
Sex and Management of Rheumatoid Arthritis 179
Tocilizumab in the treatment of rheumatoid arthritis : An evidence-based review and patient selection 178
Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome 172
The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials 170
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences 170
The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors 167
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 164
Transforming growth factor beta1 in the pathogenesis of autoimmune congenital complete heart block : lesson from twins and triplets discordant for the disease 163
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects 163
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept : Retrospective analysis of a local registry 161
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study 160
Arthritis and infections 158
The management of first-line biologic therapy failures in rheumatoid arthritis : current practice and future perspectives 158
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability 156
Pregnancy outcomes in women exposed to biologic treatment and affected by chronic arthritis 150
Upadacitinib and filgotinib: The role of JAK1 selective inhibition in the treatment of rheumatoid arthritis 149
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy 149
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date 148
Type I interferon therapy and its role in autoimmunity 147
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 147
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis 146
Sarilumab : patient-reported outcomes in rheumatoid arthritis 144
Relationship between sle susceptibility genes and clinical manifestations in a cohort of patients with primary antiphospholipid syndrome 141
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis 139
Is there really room for anti-rheumatic drugs in the treatment of COVID-19? 136
The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrolment: data from a systematic review and meta-analysis 135
Osteoporosis 135
The geoepidemiology of the antiphospholipid antibody syndrome 126
Vitamin D and spondyloarthritis: Review of the literature 122
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry 117
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights 114
The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience 113
Standardization of autoantibody testing : a paradigm for serology in rheumatic diseases 110
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab : results from the Italian GISEA registry 106
Is there a need for new thresholds to define remission and low disease activity by disease activity score 28 calculated with C reactive protein? real life data from a local registry 97
Structural integrity versus radiographic progression in rheumatoid arthritis 92
Comment on : Bisphosphonates and osteonecrosis of the jaw 90
Ultraviolet light exposure is not a requirement for the development of cutaneous neonatal lupus 88
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients : Results from the GISEA register 85
Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an "anchor" drug? 66
Ten-Year Drug Survival of Anti-TNF Agents in the Treatment of Inflammatory Arthritides 61
Survival on treatment with second-line biologic therapy: A cohort study comparing cycling and swap strategies 58
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis 4
Totale 8.868
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022539 25 28 16 9 17 13 36 98 71 54 45 127
2022/2023829 92 102 106 65 99 140 23 40 77 8 52 25
2023/2024520 30 42 24 43 142 38 14 27 12 23 46 79
2024/20251.595 41 146 56 144 149 90 119 153 89 129 154 325
2025/20263.624 299 224 380 288 305 209 587 114 280 209 394 335
2026/2027255 255 0 0 0 0 0 0 0 0 0 0 0
Totale 8.868